Resveratrol pretreatment improved the function of mesenchymal stem cells in the recovery of spinal cord injury by stimulating the secretion of nerve growth factor.
Salimi A., Salarinia R., Bibak B., Ahmadpour S., Seddigh A., Forqani MA.
Randomized Controlled Trial on Spinal Cord Injury, published in J Mol Histol (2025) — summary generated from the PubMed abstract.
Several human studies show positive signals, while research methods and sample sizes continue to develop.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Randomized Controlled Trial
- Journal
- J Mol Histol (2025)
- Country
- Netherlands
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 40753358
- DOI
- 10.1007/s10735-025-10541-0
Abstract (original English)
Depending on its severity, spinal cord injury (SCI) can cause bowel and bladder incontinence, sensory abnormalities, muscle paralysis, and lifelong disability. Enhancing the biological properties of stem cells before transplantation can improve the efficacy of cell therapy. Resveratrol has recently been used to enhance mesenchymal stem cells' (MSCs') paracrine capacity for tissue repair. Our goal was to implant mesenchymal stem cells (MSCs) into a rat spinal cord injury (SCI) model after pre-treating them with resveratrol. First, MSCs were isolated from adipose tissue. Then, the cells were treated with resveratrol, and the amount of nerve growth factor (NGF) in the supernatant was measured. Rats were randomly assigned to four groups and given a weight-drop technique to cause spinal cord injury. MSCs were injected into the site of injury 30 min after SCI. A functional recovery test was conducted over four weeks. Luxal fast blue and hematoxylin-eosin staining were done to evaluate the tissues. The concentration of 0.2 micromolar of resveratrol increased the expression of NGF in the supernatant of MSCs. There was a significant increase in the average motor function scores in the fourth week after the injury in animals that received stem cells treated with resveratrol compared to the SCI group. This study demonstrated that transplanted MSCs treated with resveratrol exhibit better e
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
Evidence level
Several human studies show positive signals, while research methods and sample sizes continue to develop.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewPubMed
Host immune determinants of stromal vascular fraction graft survival: Toward a concept of SVF therapy resistance - A systematic narrative review.
Systematic Review on Spinal Cord Injury, Chronic Inflammation, Immune Modulation, published in Cell Transplant (2026) — summary generated from the PubMed abstract.
- 2026
Cell Transplant - Level AMeta-analysisPubMed
Stem cell-derived exosome treatment for acute spinal cord injury: a systematic review and meta-analysis based on preclinical evidence.
Meta-analysis on Spinal Cord Injury, published in Front Neurol (2025) — summary generated from the PubMed abstract.
- 2025
Front Neurol - Level ASystematic ReviewPubMed
Brain-derived neurotrophic factor (BDNF) as biomarker in stem cell-based therapies of preclinical spinal cord injury models: A systematic review.
Systematic Review on Spinal Cord Injury, published in Tissue Cell (2025) — summary generated from the PubMed abstract.
- 2025
Tissue Cell3 citations - Level ASystematic ReviewEurope PMC
Revolutionizing neural regeneration with smart responsive materials: Current insights and future prospects
Systematic Review on Spinal Cord Injury, published in Bioact Mater (2025) — summary generated from the PubMed abstract.
- 2025
Bioact Mater5 citations - Level ASystematic ReviewEurope PMC
Conductive Nanocomposite Hydrogels for Neural Tissue Engineering: A Systematic Scoping Review of Recent Trends
Systematic Review with a reported sample of 42 on Diabetic Foot, Stroke Research, Spinal Cord Injury, Neuroinflammation, published in Adv Sci (Weinh) (2025) — summary generated from the PubMed abstract.
- 2025
- n = 42
Adv Sci (Weinh)18 citations - Level ASystematic ReviewEurope PMC
Emerging regenerative strategies for spinal cord injury: exosome-derived mechanisms and therapeutic insights
Systematic Review on Spinal Cord Injury, Neuroinflammation, published in Front Neurosci (2025) — summary generated from the PubMed abstract.
- 2025
Front Neurosci